ABSORPTION PHARMACEUTICALS- lidocaine gel

Absorption Pharmaceuticals by

Drug Labeling and Warnings

Absorption Pharmaceuticals by is a Otc medication manufactured, distributed, or labeled by Absorption Pharmaceuticals LLC, Inspec Solutions LLC.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingerdient

Lidocaine 10 mg

Purpose:

Male Genital Desensitizer

Use:

Help in temporarily slowing the onset of ejaculation

Warnings:

For external use only

Do not use if:

You or your partner are allergic to lidocaine or topical anesthetics.

When using this product:

Avoid contact with eyes

Do not spray on broken skin or sensitive skin

Stop use and ask a doctor

This product is used and does not provide relief. Premature ejaculation requiring medical supervision

You or your partner develop a rash or irritation, such as burning or itching.

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center immediately

Ask a doctor or pharmacist before use

If you have liver problems

If your partner, or may be pregnant

Directions

Gently shake bottle. Hold upright and press pump until spray dispenses. Apply 3 or more sprays, not to exceed 10, to head and shaft of penis 10 minutes before sexual intercourse or use ad director by a doctor.

Wash product off after intercourse.

Other information

Store at 68 - 77° F (20 -25° C)

Inactive ingredient

Acrylates/C10-30 Alkyl Acrylate Crosspolymer

Cetearyl Alcohol

Citric Acid

Ceteareth-20

Dimethicone

Farnesol

Fragrance

Glycerin

Hydrogenated Polyisobutene

Macadamia Ternifolia Seed Oil

Panthenol

Phenoxyethanol

SD Alcohol 40-B

Sodium Hydroxide

Soy lecithin

Stearoxytrimethylsilane

Stearyl Alcohol

Thymol

Vitamin E Acetate

Water

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

ABSORPTION PHARMACEUTICALS 
lidocaine gel

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 55636-101
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE	10 mg  in 100 mg

Inactive Ingredients
Ingredient Name	Strength
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
HYDROGENATED POLYISOBUTENE 8 (UNII: 7YR4ZFS62E)
SOYBEAN LECITHIN (UNII: 1DI56QDM62)
CETEARYL ALCOHOL (UNII: 2DMT128M1S)
WATER (UNII: 059QF0KO0R)
GLYCERIN (UNII: PDC6A3C0OX)
MACADAMIA TERNIFOLIA SEED OIL (UNII: 515610SU8C)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
THYMOL (UNII: 3J50XA376E)
CETEARETH-20 (UNII: YRC528SWUY)
DIMETHICONE (UNII: 92RU3N3Y1O)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
PANTHENOL (UNII: WV9CM0O67Z)
STEAROXYTRIMETHYLSILANE (UNII: 9862TW94B2)
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)
FRAGRANCE 13576 (UNII: 5EM498GW35)
FARNESOL (UNII: EB41QIU6JL)
ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (60000 MPA.S) (UNII: 8Z5ZAL5H3V)
CITRIC ACID (UNII: 2968PHW8QP)
ALCOHOL (UNII: 3K9958V90M)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 55636-101-01	2.6 mg in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	12/17/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M011	12/17/2024

Labeler - Absorption Pharmaceuticals LLC (014937753)

Registrant - Inspec Solutions LLC. (081030372)

Establishment
Name	Address	ID/FEI	Business Operations
Inspec Solutions LLC.		081030372	manufacture(55636-101)